© Copyright Nostre Net
Ascites is caused due to abnormal
accumulation of fluids in the peritoneal cavity and is mainly triggered by
other disorders such as acute liver failure, liver cirrhosis, cancer,
pancreatic disorders, heart failure, ovarian diseases, hypothyroidism and others.
Market Research Future (MRFR), the Ascites
Market size is anticipated to reach USD 2240.12 Million by 2030 at
3.80% CAGR during the forecast period 2022-2030.
Market Drivers and Restraints:
Increasing alcohol abuse, changing
lifestyles and other factors are leading to the rise in prevalence of liver
cirrhosis which is triggering the incidences of ascites. This rise in ascites
incidences is inducing high demand for effective treatments, leading to the
significant growth of the global ascites market. Proliferation of cancer
patients all over the world and increasing prevalence of diabetes are some
other factors that are driving the expansion of the global ascites
market.
However, complexities regarding the
diagnosis and treatment procedures and low awareness of the disease in the
underdeveloped regions are likely to restrain the expansion of the global
ascites market during the assessment period.
Key Players:
The prominent players that are profiled by
MRFR in the report on the global ascites market are Sequana Medical, BioVie,
PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, Medtronic plc, BD, GI
Supply, and others.
Segmental Analysis:
The global ascites
market insights has been segmented by type, treatment, diagnosis and end
user. Based on type, the ascites market has been segmented into transudative
ascites, malignant ascites and exudate ascites. Based on diagnosis, the ascites
market has been segmented into ultrasound, CT scan, laparoscopy, angiography,
and others.
Based on treatment, the ascites market has
been segmented into surgeries and others. The surgeries segment has been
sub-segmented into peritoneovenous shunting, liver transplantation,
transjugular intrahepatic portosystemic shunt (TIPS), and others. Based on end
-users, the ascites market has been segmented into hospital, and clinics,
ambulatory surgical centers, diagnostic centers, and others.
Regional Analysis:
The global ascites market has been
geographically segmented into four major regions such as Europe, Asia Pacific,
the Americas and the Middle East and Africa. The Americas are projecting
dominance over the global ascites market owing to the high prevalence of liver
diseases caused due to increased alcohol consumption and changing lifestyle and
easy adoption of advanced treatment methods in the well-developed healthcare
infrastructure in this region.
The ascites market in the Europe region is
majorly driven by rapid incorporation of advanced technologies in the
healthcare sector, high healthcare expenditure and increased government funding
for research and development of effective treatments in this region. The Asia
Pacific region is growing at fastest rate in the global ascites market due to
increasing awareness regarding ascites and its causative factors and
inclination of population towards getting proper treatment for the disease. The
Middle East and Africa region is anticipated to project steady growth in the
global ascites market owing to the poor primary health care facilities and lack
of awareness in the underdeveloped countries of this region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
As per the market analysis, The skin graft
market is expected to reach USD 4,400 Million by 2030 at 7.01% CAGR during the
forecast period 2022-2030. Skin Graft Market Share is growing
at a rapid rate owing to increasing cases of skin cancer, burns, and other
wounds. In skin grafting, healthy skin is taken from an area of the body to
cover the damaged and lost skin.
The increasing cases of skin infections,
burn injuries, and surgeries have contributed to the growth of the Skin Graft Market worldwide. The
process of skin grafting is complex and expensive. This may restrain the growth
of the Skin Graft Sector in the coming years.
COVID-19
Analysis
The onset of the COVID-19 pandemic has
affected all industry sectors, and the Skin
Graft Market is no different. Due to strict lockdown measures, many
planned surgeries were postponed. This affected the Skin Graft Market Growth.
During the pandemic, the availability of fully processed skin used for needed
for burn patients was limited. The dip in non-planned medical visits, delay in
diagnosis of skin cancer, lack of skilled healthcare etc., affected the growth
of the Skin Graft Market
negatively. But, the market is reviving, and companies are investing in
surgical settings and technological improvements to treat burn patients and
patients diagnosed with skin cancer. These factors will help the Skin Graft Market Size to grow
significantly in the coming years.
Key
Players:
The Skin
Graft Market is huge. There are regional and global players in this
market. The Key
Skin Graft Market Players are adopting strategies, such as partnerships,
mergers, acquisitions, product launches, and product upgradation, to remain at
the top and dominate maximum Skin Graft
Market Share. In 2017, EXSURCO introduced a new skin
and wound grafting device to be used for burn centres. In 2019, a prosthetic
limb socket was developed from recycled plastic bottles at De Montfort
University.
Market
Segmentation
The global Skin Graft Market is segmented based on type, thickness,
equipment, application, end-users, and region.
Based on graft type, the sub-segments are
allogeneic, autologous, xenogeneic, isogeneic, and prosthetic.
Based on thickness, the sub-segments are
full-thickness, split-thickness, and composite graft.
Based on equipment, the sub-segments are
air dermatomes, electric dermatomes, drum dermatomes, and knife dermatomes.
Based on end-users, the sub-segments are
hospitals, ambulatory surgical centres, dermatology clinics, and academic
research centres.
Based on application, the sub-segments of
the Skin Graft Market are burnt
skins, surgical wounds, skin cancer, and infection.
Regional
Classification
The Skin
Graft Market is segmented into these regions- North America, Europe,
South America, Asia-Pacific, and the Middle East and Africa. The North American
region is expected to dominate the maximum Skin Graft Market Revenue during the forecast period 2022-2028.
The huge investment in healthcare, favourable reimbursement of skin-care
treatment and adoption of new technologies in this region will contribute to
the growth of the Skin Graft Market
significantly. Europe will hold the 2nd largest position in the Skin Graft Market.
The Asia-Pacific region will also witness
significant growth in this sector owing to rising demand for skin grafting,
favourable government initiatives for burn and trauma patients, and skilled
surgeons.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The global asthma devices market is witnessing a revolution
owing to the influx of smart inhaler devices and the rising number of asthma
patients. The Asthma
Devices Market is projected to reach USD 7202.6 Million by 2030 at 4.7%
CAGR during the forecast period 2022-2030.Growing incidence of asthma and
exposure to risk factors are the prime driving factors behind the market
growth.
According to the Centers for Disease Control and Prevention
(CDC)reports, almost 25 million US citizens suffer from asthma representing
7.7% of adults and 8.4% of children. The rising rates of asthma cases are
further increasing market growth. CDC states that approximately 11.4 million US
patients had more than one asthma episode in 2017. Asthma also
disproportionately affects more children than adults and affects almost 6.2
million patients under 18 years of age, and a whopping 47.5 percent of children
reported more than one asthma attack.
The large economic burden due to asthma and the excellent
reimbursement rates and insurance coverage of asthma is another driver of the
market. Asthma results in 9.8 million physician visits and 1.8 million
emergency visits per year in the US The high mortality associated with asthma
and the poor elasticity of demand is another driver of the market. In 2017
alone, 3,564 US mortalities were associated with asthma.
New product development, such as the emergence of smart
inhalers, is expected to increase the market demand. Additional factors that
are substantiating the market growth are exposed to risk factors such as
sedentary lifestyles, pollution, and others.
Global Asthma Devices Market – Segments
MRFR has segmented the market into five market dynamics to
widen the scope of understanding,
By Type :
Inhalers (Metered-Dose Inhalers and Dry Powder Inhalers), Nebulizers
(Compressor Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers), among others.
By Technology : Inhaler Devices, Digitally Operated Inhaler Devices, Manually
Operated among others.
By End-use :
Hospital, Clinics, Retail Pharmacies among others.
By Regions :
Europe, Asia Pacific, North America, and the Rest-of-the-World.
Global Asthma Devices Market – Regional Analysis
North America accounts for the significant share in the
global asthma devices market owing to a large patient base and high healthcare
expenditure. According to the CDC, approximately 9.8% of women and 5.4% of men
have asthma, which makes for a large market. Excellent healthcare reimbursement
is another driver of the market.
Europe accounts for the second-largest asthma devices market
due to excellent healthcare infrastructure and large government support for
research & development. According to the Asthma Research and Practice
journal, the annual cost of asthma treatment per person in 2017, was about USD
1,900. The presence of large medical device companies in Germany is further
boosting the market growth.
The Asia Pacific is projected to drive further market growth
owing to low treatment rates and the growing population. According to the
Indian Chest Society, account for 10% of the global asthma burden. According to
the Indian Brand Equity Foundation, the Indian healthcare sector is projected
to grow at 22.8% CAGR and expand to more than USD 280 billion by the end of
2020. Favorable excise and customs policies such as exemptions from service tax
are boosting the market growth.
Global Asthma Devices Market – Competitive Landscape
The asthma devices market is fragmented and competitive
owing to large pricing pressures, especially at low-end devices. However, the
smart devices segment is consolidated and yields a premium owing to features
such as online and mobile connectivity and analytics. Consolidation of data and
precise measurement of dose are other features available. Moreover, the latest
asthma devices can predict the need and timing of the dose, helping the patient
manage his condition. Manufacturers of asthma devices are developing a close
association with healthcare end-users such as hospitals, enhancing their
exposure to end-users.
Major Players:
Players leading the global asthma devices market
include GlaxoSmithKline plc. (Europe), Merck & Co., Inc. (US), 3M (US),
Aristopharma Ltd. (Asia Pacific), SRS Pharmaceuticals Pvt. Ltd. (Asia Pacific),
AstraZeneca (Europe), Baxter(US), Boehringer Ingelheim GmbH (Europe), and
Koninklijke Philips N.V. (Europe), among others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Surgical
Instrument Tracking Systems Market Trends was valued at USD 0.25 billion in
2022. The surgical instrument tracking systems market industry is projected to
grow from USD 0.278 Billion in 2023 to USD 0.53 billion by 2030, exhibiting a
compound annual growth rate (CAGR) of 11.50% during the forecast period (2023 -
2030). Surgical instrument tracking systems are incredibly effective
systems that assist healthcare providers. It basically comprises of software,
hardware, and service. The specialty of this tracking system is it can work
wonders in enhancing staff productivity, enhancing patient safety, and
decreasing case delays.
Various factors are propelling the surgical instrument
tracking system market growth. Some of these factors include growing need for
better patient care and inventory management, unique device identification
regulations by FDA, growing prevalence of retained surgical instrument,
increasing number of surgeries, growing need for inventory management, growing
use of medical devices, growth of surgical instruments, and investments by
public and private hospitals, and technological advancements.
On the flip side, the unreliability of barcode systems,
lengthy investment cycles, budgetary limitations, and huge system costs are
factors that may hamper the surgical instrument tracking system market growth
over the forecast period.
Market Segmentation
The Market Research Future report provides a complete
segmental analysis of the surgical instrument tracking system market based on
types, end users, and component.
Based on type, the surgical instrument tracking system
market is segmented into radio
frequency identification, barcode tracking, electronic tracking, and
others. Of these, the barcode tracking segment will have the largest share in
the market over the forecast period. It is the most extensively used,
especially in the medical devices industry, which is adding to the growth of
the segment.
Based on end users, the surgical instrument tracking system
market is segmented into laboratories, research facilities, clinics, hospitals,
and others. Of these, the hospitals segment will dominate the market over the
forecast period. This is owing to the high inflow of patients in hospitals
compared to others. Moreover, hospitals use more instruments and equipment and
perform a higher number of surgical procedures compared to other forms of
healthcare providers.
Based on the component, the surgical instrument tracking
system market is segmented into services, software, and others. Of these, the
software segment will lead the market over the forecast period owing to the
introduction of new software applications and frequent need for upgrades.
Regional Analysis
Based on the region, the surgical
instrument tracking system market report covers the latest trends and
growth opportunities across North America, Europe, the Middle East and Africa,
and the Asia Pacific. Of these, North America will have the lion’s share in the
market over the forecast period chiefly due to the increasing adoption of
surgical instrument tracking systems, highly developed healthcare
infrastructure, accessibility of advanced products, and the UDI regulations by
the FDA. The US is the chief contributor in the region.
The surgical instrument tracking system market in Europe is
predicted to have the second-largest share in the market over the forecast
period. This is chiefly on account of growing private funds, government
initiatives, the emergence of better and high-quality healthcare
infrastructure, cost advantage, rising healthcare sector privatization, and
rising medical tourism.
The surgical instrument tracking system market in the APAC
region is predicted to grow at the fastest pace over the forecast period.
Factors aiding the growth of the surgical instrument tracking system market in
the region include rapidly evolving healthcare infrastructure, increasing
geriatric population, healthcare industry from other regions shifting to APAC,
and better health management. China, as well as India, are the leading
contributors in this region.
The surgical instrument tracking system market in the MEA is
predicted to have a small share in the market over the forecast period.
Key Players
Major players profiled in the surgical instrument tracking
system market report include Key Surgical (US), Mobile Aspects, Inc. (US), TGX
Medical Systems (US), Infor (US), STANLEY Healthcare (US), Censis Technologies,
Inc. (US), B. Braun Melsungen AG (Germany), Dickinson and Company (US), and
Becton. Key players have incorporated different strategies to create a foothold
in the market, such as partnerships/joint ventures, R&D activities, mergers
and acquisitions, product innovations, and more.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and
Market Research & Consulting Services.
The stent is a small, flexible metal or plastic tube that
are inserted into the vessels or duct to keep the passageway open. Different
types of materials like metal, standard polymer, and biodegradable polymer are
used for the preparation of the surgical stents. According to the WHO (2015),
more than 35% of the total global population was suffering from major or minor
cardiovascular complications; and in 2014, globally 39% of adults aged 18 years
and over were overweight whereas, 13% were obese. The Surgical
Stents Market is expected to reach USD 20,437.3 Million by 2030 at 9.8%
CAGR during the forecast period 2022-2030.
The Market is going to continue with the same trends of
growth during the forecast period. The major factors influencing the growth of
the market include increasing prevalence of cardiovascular diseases, rising
burden of CAD, rising diabetic & obese population, increase in the numbers
of percutaneous coronary intervention (PCI) procedures, increasing demand for
nominally invasive procedures and rapid development in the technology.
Moreover, rising healthcare expenditure, increasing geriatric population, and
changing lifestyle have fuelled the growth of the market.
Surgical Stents Market - Competitive
Analysis
Charaterized by the existence of several well-established
and small players, the global market of surgical market appears to be highly
fragmented and competitive. Europe holds the largest market share in terms of
revenue; mainly due to the strategic presence of key stents manufacturers in
Germany and the U.K.
North America being the second-largest market for surgical
stents globally and is likely to expand at a significant CAGR over the
2017-2025 forecast period. However, Asia Pacific is expected to display the
leading CAGR over the forecast period as huge business groups are investing
significantly for the modernization of the healthcare sector in India and
China. With well-established market in the North America region major companies
like Boston Scientific Corporation, Abbott, Laserage Technology corporation,
have their home in the region and generate maximum market share. These
companies have also expanded their operating units in various other emerging
regions. Moreover, the other small and medium scale players are generating
revenue from local market.
Abbott an American multinational company headquartered in US
is one of the leading players in the surgical stents market. It has the largest
portfolio of heart-valve repair and replacement technologies and maintains a
strong position in the developed markets. Abbott covers 58% of the developed
markets and 42% of the emerging markets. Abbott has long been a leader in
vascular care, through its stents and related products. In recent years, the
company has acquired a strong position in mitral valve repair with its
MitraClip device. In January 2017, the company acquired St. Jude Medical, this
widens Abbott's vast product portfolio for cardiovascular care and will make
Abbott a leading brand in medical device market. With St. Jude, Abbott's
Medical Devices business will have newly-launched and pipeline technologies
across a wide range of medical technologies. This combined pipeline is likely
to deliver several new products. Abbott, following the acquisition of Piramal
Healthcare's formulation division in 2010, is setting up an Innovation and
Design Centre in Mumbai, which will take off next year. The US FDA has
sanctioned approval for the next-generation version of its leading MitraClip
heart valve repair device which is used to restore a leaky mitral valve without
an open-heart surgery.
Furthermore, Boston Scientific Corporation, headquartered in
the US, is a global manufacturer and developer of medical devices. The company
has adopted various strategies to sustain in the competitive market, for
instance, new products launch. PROMUS Element Plus Stent, REBEL Stent System,
SYNERGY Stent are some of the major products of the company. In 2015, worldwide
sales of the company’s drug-eluting coronary stents were USD1.074 billion as
compared to USD 1.151 billion during 2014.
Medtronic, headquartered in UK, is a world's largest
standalone medical device manufacturer. In 2015 company has develop Stent Graft
System System for Endovascular Repair of Thoracoabdominal Aortic Aneurysms.
Earlier company’s Resolute Drug-Eluting Stent has shown a very good performance
in Diabetic Patients with Heart Disease.
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients. Our market
research studies by products, services, technologies, applications, end users,
and market players for global, regional, and country level market segments,
enable our clients to see more, know more, and do more, which help to answer
all their most important questions.
The Global hospital furniture market has
been witnessing upswings in the recent years and presents a positive outlook
for the forthcoming years. According to Market Research Future (MRFR)'s
analysis, Hospital
furniture market size was valued at USD 7.8 billion in 2021 and is
projected to grow from USD 8.5 Billion in 2022 to USD 16.5 billion by 2030,
exhibiting a compound annual growth rate (CAGR) of 9.90% during the forecast
period (2022 - 2030). With the rapid increase in a number of hospitals and
healthcare centers around the world, and emphasis being laid to provide
improved facilities is the primary driving force behind the growth of the
market. The government in various developing countries is encouraging new
hospitals in the private sector in order to increase treatment facilities in
accordance with the latest developments.
Increasing patient expectations towards
better hospital infrastructure also have a catalyzing effect on the growth of
the global hospital furniture market. In the midst of the urban environment,
various old hospitals and healthcare institutions are renovating their outdated
hospital furniture. Thus, renovation of hospitals also spurs the market growth.
Other driving factors for the growth of the market include increasing
healthcare expenditure, persistent development in technology and innovations in
hospital furniture. Whereas, long life of furniture and the substantial cost
associated with them are the most prominent hurdles to the growth of the global
clinics furniture.
Competitive Landscape
The global hospital
furniture market players include KI (US), GPC Medical (India), Stryker
Corporation (US), Beaver Healthcare Equipment (UK), The Brewer Company (US),
Beaver Healthcare Equipment (UK), DRE INC (US), Renray Healthcare Ltd. (UK),
Moore Medical LLC (US), Bio Medical Solutions (India), GPC Medical Ltd (India),
Anetic Aid Limited (UK), Hill-Rom (US), Chang Gung Medical Technology (China),
Narang Medical (India), Bristol Maid Hospital Metalcraft (UK).
Segmentation
The global hospital furniture market has
been segmented based on type, application, and end users. By type, the hospital
furniture market has been segmented into bedside tables, OT table, instrument
stands, stretchers, hospital
beds, chairs, scrub sinks, waste container, trolley, and others. By
application, the hospital furniture market has been segmented into physician
furniture, patient’s furniture, and staff’s furniture. The physician furniture
segment has been segmented into examination table, surgery chair and other. The
patient furniture segment has been further segmented into stretchers, bedside
table, and others, while the staff's furniture segment has been further
segmented into stands and other. By end users, the hospital furniture market
has been segmented into hospital, diagnostic centers, clinics, and
others.
Regional Analysis
The global hospital furniture market spans
across the regions of the Americas, Europe, Asia Pacific, and the Middle East
& Africa. The Americas has commanded the dominant position in the global
hospital furniture market. High healthcare spends, and soaring demand for
better infrastructure and medical facilities have accelerated the market in the
Americas. Europe and Asia Pacific account for nearly same share of the global
hospital furniture market, but Asia Pacific market is expected to expand at a relatively
faster rate than other markets. Growing burden of various diseases has resulted
in higher demand for healthcare centers which has contributed to the growth of
the market. Moreover, rapid development in the healthcare sector and rising
healthcare expenditure in the developing economies of the region aid the
expansion of the market. The presence of key players in the region and high
investment in healthcare sector substantiates the growth of the Europe market.
The Middle East & Africa market account for the least share of the market
due to low expenditure on healthcare.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The global cardiac
catheterization market is accruing pervasively mainly due to the growing
rate of cardiovascular disorders, worldwide. Currently, the world is witnessing
the increasing number of cardiac disorders cases and issues related to heart
diseases. Sadly, the figure is expected to grow every year; despite the several
innovative therapies and procedures. The rising prevalence of these diseases is
becoming a major concern fuelling the growth of the global cardiac
catheterization market.
Acknowledging the fiercely ascending
market, Market Research Future (MRFR) in its recently published study report
asserts that the global The Cardiac Catheterization Market is anticipated to
reach USD 531.3 Million by 2030 at 6.6% CAGR during the forecast period
2022-2030.
Rising technological advancements
transpired in the field of heart care, bringing a diversity of engineering and
design backgrounds, privacy, liability, and financial perspectives necessary to
succeed in a complex health care system. Global Cardiac Catheterization market
is growing as continuously increasing the patients suffering from arterial
diseases. Changing lifestyle, an increasing number of the patient suffering
from obesity and diabetes has also helped to expand the market of the cardiac
medical device manufacturing.
Cardiac Catheterization Market –
Segments
The market is segmented into five Key
dynamics for an easy grasp.
By Procedures : Balloon Septostomy, Coronary Angioplasty, Catheter Ablation, Bipolar
Pacing, Left Heart Catheterization, and Right Heart Catheterization among
others.
By Types : Fractional Flow Reserve, Coronary Angiogram, Intravascular
Ultrasound, and Optical
Coherence Tomography among others.
By Applications: Heart
Attack, Abnormal Stress Test, Coronary Vasospasm, and Cardiac Arrhythmia, among
others.
By End-Users : Hospitals and Clinics among others.
By Regions : Comprises Geographical regions - North America, Europe, APAC
and Rest of the World.
Key Players:
Some of the eminent leaders of the Cardiac
Catheterizationmarket players include Coloplast (Denmark), Boston
Scientific Corporation (US), Dispocard GmbH (Germany), St. Jude Medical (US),
Becton, Dickinson and Company (US), Abbott (US), Teleflex Incorporated (US).,
Johnson & Johnson Private Limited (US), Smiths Medical (US), Medtronic Inc
(US), Edwards Life Sciences Corporation (US), Rochester Medical Corporation
(U.S), Terumo Medical Corporation (Japan), and Maquet Medical India Private
Limited (India).
Cardiac Catheterization Market -
Regional Analysis
The North American region accounts for the
global leader for the cardiac catheterization market owing to the increasing
prevalence of cardiovascular diseases among the rising geriatric population,
vulnerability to hypertension and obesity issues leading to the heart diseases
and disorders. The market is constantly growing due to huge people
suffering from major or minor heart issues.
Additional factors substantiating the
market growth include increasing government initiatives and funding for
research, rising demand for technologically advanced cardiac catheterization
treatments, and the developments in advanced medical treatment options.
The European region is the second-largest
market for cardiac catheterization. Attributing to the increasing healthcare
expenditure and availability of advanced treatment facilities, along with the
government initiatives of healthcare, the European market is estimated to
register a phenomenal CAGR during the forecast period.
Cardiovascular disease is one of the major
concerns in Europe; it significantly contributes to the market growth in this
region. Growing rate of cardiovascular disorders alongside government
initiatives are expected to positively impact the market growth of the cardiac
catheterization market in this region.
The Asia Pacific region is rapidly emerging
as a promising market for cardiac catheterization. Increasing geriatric
population alongside the prevalence of cardiac disorders and diabetes growing
at an alarming rate is fostering the market growth in the APAC
region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Hospital beds are a special type of bed
that have been designed to serve the hospitalized patients. These beds can be
both electric and semi-electric ones. The global hospital beds market is
gaining high traction due to the increase in geriatric population and people
suffering from diseases. The Hospital beds market size was valued at USD 3.1
billion in 2021 and is projected to grow from USD 3.33 Billion in 2022 to USD
5.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.50%
during the forecast period (2022 - 2030). Market Research Future (MRFR) in
their latest analysis of the global hospital beds market report opens up
potentials that can impact the market in the coming years.
Hospital Beds Market overview analysis By Type, By Power, By End Users -
Forecast till 2030. Several factors are expected to
take the global hospital beds market ahead. Hike in investment for the
healthcare sector is expected to play in favor of the global hospital bds
market. Patient-centric service is also expected to ensure strong growth for
the market as managements are going to buy new ones to increase the level of
comfort for the market. However, the high price can be a growth
deterrent.
Competitive Landscape:
Various market players are showing
substantial interest in the global hospital beds market. The global market can
be inspired by the strategic moves implemented by these companies to cement
their individual growth and in the process, they are taking the global market
ahead. MRFR, in their report on the market, profiled quite a few companies.
These companies are by Stryker Corporation, Hill-Rom Holdings, Invacare
Corporation, Linet spol. s r.o., Gendron Inc., Paramount Bed Holdings Co.,
Ltd., and Getinge AB.
Regional Analysis:
The Americas, Europe, Asia Pacific (APAC),
and the Middle East & Africa (MEA) are four regions that have been included
in the global hospital beds market report, studied by MRFR. This report has a
special focus on the growth pockets that can be explored later for a better
understanding of the market flow.
Europe is dominating the global market that
depends mostly on the contribution made by Western Europe where countries like
France, Germany, the U.K, Spain, Italy, and others are doing great. The eastern
region does not promise high growth as several countries are there with not
much of strong economies. The Europe hospital beds market had a valuation of
USD 916.6 million in 2016 and is at present, deemed to grow with a CAGR of 5.5%
during the forecasted period.
The Americas stands in the second spot.
This growth is due to robust infrastructure, huge geriatric population,
substantial investment capacity, high per capita income, and other features. It
is also getting the benefits of the presence of countries like the U.S. and
Canada who spend substantially to take the regional market ahead.
Segmentation:
MRFR has made an attempt to read the global
hospital
beds market Research Report closely by segmenting it on the basis of type,
power, and end-users. This analysis has a strong foundation in the volume-wise
and value-wise analysis of the global market.
Based on types, the global hospital beds
market includes long-term care, acute
care, psychiatric & bariatric care, and others (maternity and
rehabilitation beds). The global smart hospital beds of the future market is
expecting strong growth from the long-term care segment.
By power, the hospital beds market
comprises electric bed, semi-electric bed, and manual bed. The electric bed
segment is expected to receive strong traction due to hike in the global
healthcare expenditure and investment to increase level of comfort for
patients.
By end-users, the global hospital beds
market includes hospital, clinics, ambulatory, and others. The hospital segment
is expected to grow notably.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.